Literature DB >> 10921992

Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture.

D B Shelly1, T Spilker, E J Gracely, T Coenye, P Vandamme, J J LiPuma.   

Abstract

Performances of several commercial test systems were reviewed to determine their relative levels of accuracy in identifying Burkholderia cepacia complex isolates recovered from cystic fibrosis sputum culture. Positive predictive values ranged from 71 to 98%; negative predictive values ranged from 50 to 82%. All systems misidentified B. cepacia complex. The species most frequently misidentified as B. cepacia was Burkholderia gladioli. These data support the results of previous studies that recommend confirmatory testing, including the use of DNA-based methods, for sputum culture isolates presumptively identified as B. cepacia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921992      PMCID: PMC87204     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

Review 1.  Burkholderia cepacia. Management issues and new insights.

Authors:  J J LiPuma
Journal:  Clin Chest Med       Date:  1998-09       Impact factor: 2.878

2.  Species-specific PCR as a tool for the identification of Burkholderia gladioli.

Authors:  P W Whitby; L C Pope; K B Carter; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods.

Authors:  C van Pelt; C M Verduin; W H Goessens; M C Vos; B Tümmler; C Segonds; F Reubsaet; H Verbrugh; A van Belkum
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

4.  Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates.

Authors:  J D McMenamin; T M Zaccone; T Coenye; P Vandamme; J J LiPuma
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

Review 5.  Burkholderia cepacia epidemiology and pathogenesis: implications for infection control.

Authors:  J J LiPuma
Journal:  Curr Opin Pulm Med       Date:  1998-11       Impact factor: 3.155

6.  Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov.

Authors:  T Coenye; E Falsen; B Hoste; M Ohlén; J Goris; J R Govan; M Gillis; P Vandamme
Journal:  Int J Syst Evol Microbiol       Date:  2000-03       Impact factor: 2.747

7.  Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients.

Authors:  J J LiPuma; B J Dulaney; J D McMenamin; P W Whitby; T L Stull; T Coenye; P Vandamme
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

8.  Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.

Authors:  D L Kiska; A Kerr; M C Jones; J A Caracciolo; B Eskridge; M Jordan; S Miller; D Hughes; N King; P H Gilligan
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

9.  Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources.

Authors:  L A Carson; O C Tablan; L B Cusick; W R Jarvis; M S Favero; L A Bland
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

10.  Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications.

Authors:  D R Burdge; M A Noble; M E Campbell; V L Krell; D P Speert
Journal:  Clin Infect Dis       Date:  1995-02       Impact factor: 9.079

View more
  23 in total

1.  Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.

Authors:  D A Henry; E Mahenthiralingam; P Vandamme; T Coenye; D P Speert
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex.

Authors:  Sylvain Brisse; Stefania Stefani; Jan Verhoef; Alex Van Belkum; Peter Vandamme; Wil Goessens
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

Review 3.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center.

Authors:  Agnes Ferroni; Isabelle Sermet-Gaudelus; Eric Abachin; Gilles Quesne; Gerard Lenoir; Patrick Berche; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

5.  Ability of the MicroScan rapid gram-negative ID type 3 panel to identify nonenteric glucose-fermenting and nonfermenting gram-negative bacilli.

Authors:  Caroline M O'Hara; J Michael Miller
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

6.  Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis.

Authors:  Juyan Zhou; Elizabeth Garber; Manisha Desai; Lisa Saiman
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

7.  Validation of Vitek 2 nonfermenting gram-negative cards and Vitek 2 version 4.02 software for identification and antimicrobial susceptibility testing of nonfermenting gram-negative rods from patients with cystic fibrosis.

Authors:  Ines Otto-Karg; Stefanie Jandl; Tobias Müller; Beate Stirzel; Matthias Frosch; Helge Hebestreit; Marianne Abele-Horn
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

8.  Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection.

Authors:  E Berriatua; I Ziluaga; C Miguel-Virto; P Uribarren; R Juste; S Laevens; P Vandamme; J R Govan
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

9.  Identification of potential diagnostic markers among Burkholderia cenocepacia and B. multivorans supernatants.

Authors:  Tiffany Mott; Michael Soler; Sierrah Grigsby; Ronald Medley; Gregory C Whitlock
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

10.  PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients.

Authors:  Theodore Spilker; Tom Coenye; Peter Vandamme; John J LiPuma
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.